Gennex Laboratories Balance Sheet Annual

Trade

BSE: 531739 | NSE: - | ISIN: INE509C01026 | Sector: Biotechnology & Drugs

19.47 +0.26 (1.35%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	60.50	14.50	7.99	0.88
Cash Equivalents	0.48	0.56	0.32	0.19
Short Term Investments	55.29	7.28	18.91	21.47
Cashand Short Term Investments	116.27	22.34	27.22	22.54
Accounts Receivable- Trade Net	17.81	9.42	11.31	8.95
Total Receivables Net	17.81	9.42	11.31	8.95
Total Inventory	25.18	15.69	7.74	5.02
Other Current Assets Total	2.56	1.23	0.91	1.17
Total Current Assets	161.81	48.68	47.18	37.67
Property/ Plant/ Equipment Total- Net	55.02	67.65	13.70	14.13
Intangibles Net	2.94	6.11	-	-
Long Term Investments	0.01	0.01	6.83	6.83
Note Receivable- Long Term	9.97	0.65	0.32	0.28
Other Long Term Assets Total	0.23	9.22	-	-
Total Assets	229.99	132.32	68.03	58.90
Accounts Payable	15.18	7.08	7.74	5.94
Notes Payable/ Short Term Debt	5.72	0.07	10.12	7.36
Current Portof LT Debt/ Capital Leases	13.69	0.98	-	-
Other Currentliabilities Total	5.71	21.38	6.34	5.73
Total Current Liabilities	40.30	29.51	24.21	19.04
Long Term Debt	13.22	16.29	-	-
Total Long Term Debt	13.22	16.29	0.00	0.00
Total Debt	32.63	17.34	10.12	7.36
Minority Interest	6.08	6.17	-	-
Total Liabilities	59.60	51.97	24.21	19.19
Common Stock Total	22.74	18.02	12.65	12.65
Additional Paid- In Capital	5.72	-	-	-
Retained Earnings( Accumulated Deficit)	141.92	62.33	31.16	27.06
Total Equity	170.38	80.35	43.82	39.71
Total Liabilities Shareholders' Equity	229.99	132.32	68.03	58.90
Total Common Shares Outstanding	22.74	17.66	13.26	13.26
Tangible Book Valueper Share Common Eq	7.36	4.20	3.30	2.99
Deferred Income Tax	-	-	0.00	0.15
Other Liabilities Total	-	-	-	0.00